Advertisement Vitrolife granted approval for vitrification products - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Vitrolife granted approval for vitrification products

Vitrolife has obtained approval from Health Canada for a further two new products within the fertility area. The products are used for vitrification, rapid freezing and thawing of cleavage embryos.

The two vitrification products that Vitrolife has obtained approval for are RapidVit Cleave and RapidWarm Cleave. Products for vitrification involve considerable technological progress and open up new opportunities within IVF treatment.

Nils Sellbom, director of marketing and sales at Vitrolife, said: “These are two very important new products for us, as the majority of the clinics that freeze embryos do so at the very stage that the products are intended for, day 2-3 after fertilization. We are now continuing to work on getting our systems for cold storage out in several markets.”